Lv4
460 积分 2024-11-19 加入
Endometrial cancer
14天前
已完结
Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025
14天前
已完结
Pathogenesis of rheumatoid arthritis: one year in review 2025
14天前
已完结
Antibody–drug conjugates in gynaecological cancers: opportunities and challenges
14天前
已完结
Ovarian cancer
14天前
已关闭
Ovarian cancer
14天前
已完结
Advances in Cervical Cancer
14天前
已关闭
Emerging Targeted Therapies for HER2-Mutant NSCLC
15天前
已关闭
Treatment advances across the cervical cancer spectrum
15天前
已完结
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
15天前
已完结
皖公网安备34019202002308
